COVID-19 target: A specific target for novel coronavirus detection
نویسندگان
چکیده
منابع مشابه
World and the novel coronavirus disease (COVID-19
سخن سردبیر Editorial مجله دانشگاه علوم پزشکی رفسنجان دوره نوزدهم، فروردین 1399، 2-1 جهان و بیماری کرونا ویروس جدید (کووید-19) ) World and the novel coronavirus disease (COVID-19 محسن رضائیان[1]،[2] M.Rezaeian به هنگام تکمیل این سخن سردبیری در بیست و سوم فروردین سال 1399 برابر با یازدهم آوریل سال 2020 میلادی، تقریباً صد روز از گزارش رسمی بیماری جدیدی ...
متن کاملA Review of Pharmacotherapy for Coronavirus Disease 2019 (COVID-19)
The epidemic of COVID-19 and its associated acute respiratory syndrome has posed an unprecedented challenge in identifying effective drugs to prevent and treat it. Due to the high prevalence of this disease and the high number of people at risk, medical staff needs accurate evidence regarding effective drug treatments for this infection. There is currently no effective treatment for COVID-19. B...
متن کاملa novel navigation method for pursuing a moving target
the most current pursuit algorithms for moving targets which are presented so far in the literatureare pure pursuit and pure rendezvous navigations. recently, one of the present authors has introduced ageometric model for the pure pursuit navigation algorithm. here, in this paper, we study a new algorithm forthe pursuit navigation problem which is a combination of both of the above algorithms. ...
متن کاملEnvelopment analysis for global response to novel 2019 Coronavirus-SARS-COV-2 (COVID-19)
Communities are constantly seeking to manage the damages which are caused by crises. In this regard, health centers have become the most expensive unit of the health system as they provide quick and timely health care services to reduce the effects of unexpected accidents. So, their planning and preparation should be considered as an important part of strategic health policies. The purpose of t...
متن کاملNovel antidotes for target specific oral anticoagulants
Target specific oral anticoagulants (dabigatran, rivaroxaban, apixaban, and edoxaban) are changing the landscape of anticoagulation. The major drawback is the absence of an effective antidote for severe bleedings and/or prior to procedures. Currently there are a few promising antidotes undergoing clinical trials. This review summarized the latest development in idarucizumab, andexanet alpha and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gene Reports
سال: 2020
ISSN: 2452-0144
DOI: 10.1016/j.genrep.2020.100740